Neuroparin, a mixture of oligosaccharides with average MW of 2.1 kDa obtained by gamma irradiation of heparin, crosses the blood–brain barrier and was reported to attenuate the abnormal tau immunoreactivity in rat hippocampus and to have neuroprotective effects in several animal models of AD [93,94]. This evidence concerns the gene MAPT and Alzheimer disease.